clinical trial Archive — Page 16 of 16

Close-up of a hand with a fingertip blood drop held near a blue blood glucose meter displaying a numeric reading.
September 12, 2013

VU tracking drug’s ability to prevent type 1 diabetes

Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.

By Vanderbilt Health News
Row of red upholstered waiting-room chairs along a bright wall.
July 15, 2013

Defining patient retention

Vanderbilt researchers propose guidelines for defining patient retention in clinical studies – an important parameter that affects study conclusions and program evaluations.

By Leigh MacMillan
May 30, 2013

Continuity of care initiative focuses on patients exiting clinical trials

The Vanderbilt Breast Center is piloting new measures to ensure continuity of care and timely insurance preauthorization as patients come off grant-sponsored clinical trial protocols and begin or resume standard care.

By Paul Govern
Portrait of Blythe Corbett, Ph.D., smiling and wearing a dark pinstriped jacket over a white blouse.
January 31, 2013

ResearchMatch adds registry for autism disorders

ResearchMatch, a national on-line volunteer recruitment service hosted by Vanderbilt University, has launched a sub-registry for autism spectrum disorders (ASD) to increase the participation of children and adults with autism in clinical research studies.

By Bill Snyder
Glucose level blood test
July 31, 2012

National type I diabetes prevention trial now an option for younger children

A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.

By Craig Boerner
Blue and red round candy-coated pieces arranged in separate groups on a white background, with a gap between the colors.
April 30, 2012

Better blood pressure-reducing drugs?

A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.

By Leigh MacMillan